The researchers sought to determine the type and frequency of hormonal contraceptives and ART prescribed to women with HIV infection and prevalence of resulting drug to drug interaction potential.
The study authors sought to contribute to the evidence base on gender differences in virologic and immunologic responses to ART in treatment-naïve individuals.
The patients in the study were placed into 2 groups based on their eGFR at the time of switching agents: the early-switch group (eGFR of ≥60mL/min) and the late-switch group (eGFR <60mL/min).
The exposure-adjusted incidence rate (IR) and relative rate (RR) of both MI and CAD were compared in patients receiving ABC-containing cART to those receiving non ABC-containing cART.
Want to read more?
Please login or register first to view this content.